Literature DB >> 23750027

The moral case for the clinical placebo.

Azgad Gold1, Pesach Lichtenberg.   

Abstract

Placebos are arguably the most commonly prescribed drug, across cultures and throughout history. Nevertheless, today many would consider their use in the clinic unethical, since placebo treatment involves deception and the violation of patients' autonomy. We examine the placebo's definition and its clinical efficacy from a biopsychosocial perspective, and argue that the intentional use of the placebo and placebo effect, in certain circumstances and under several conditions, may be morally acceptable. We highlight the role of a virtue-based ethical orientation and its implications for the beneficent use of the placebo. In addition, the definitions of lying and deception are discussed, clarified and applied to the clinical placebo dilemma. Lastly, we suggest that concerns about patient autonomy, when invoked as a further argument against administering placebos, are extended beyond their reasonable and coherent application.

Entities:  

Keywords:  Autonomy; Clinical Ethics; Informed Consent

Mesh:

Substances:

Year:  2013        PMID: 23750027     DOI: 10.1136/medethics-2012-101314

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  6 in total

Review 1.  Placebos Without Deception: Outcomes, Mechanisms, and Ethics.

Authors:  Luana Colloca; Jeremy Howick
Journal:  Int Rev Neurobiol       Date:  2018-04-04       Impact factor: 3.230

2.  A Kantian defence of placebo deception.

Authors:  Anton Allen
Journal:  Monash Bioeth Rev       Date:  2019-12

3.  Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.

Authors:  Stefan Franzén; Christer Janson; Kjell Larsson; Max Petzold; Urban Olsson; Gunnar Magnusson; Gunilla Telg; Gene Colice; Gunnar Johansson; Mats Sundgren
Journal:  Respir Res       Date:  2016-11-15

4.  An Exploration of Knowledge and Attitudes of Medical Students and Rheumatologists to Placebo and Nocebo Effects: Threshold Concepts in Clinical Practice.

Authors:  Mark H Arnold; Damien Finniss; Georgina M Luscombe; Ian Kerridge
Journal:  J Med Educ Curric Dev       Date:  2020-06-22

5.  Open-label placebos as adjunctive therapy for patients with depression.

Authors:  Anne Schienle; Nina Jurinec
Journal:  Contemp Clin Trials Commun       Date:  2022-06-16

6.  Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey.

Authors:  Robin Ortiz; Sara Chandros Hull; Luana Colloca
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.